ATE119395T1 - Verwendung von interleukin-4 zur steigerung der neutrophilenzahl und zur behandlung von myeloid oder monocytoid leukeamie. - Google Patents

Verwendung von interleukin-4 zur steigerung der neutrophilenzahl und zur behandlung von myeloid oder monocytoid leukeamie.

Info

Publication number
ATE119395T1
ATE119395T1 AT90308198T AT90308198T ATE119395T1 AT E119395 T1 ATE119395 T1 AT E119395T1 AT 90308198 T AT90308198 T AT 90308198T AT 90308198 T AT90308198 T AT 90308198T AT E119395 T1 ATE119395 T1 AT E119395T1
Authority
AT
Austria
Prior art keywords
interleukin
leukeamia
monocytoid
neutrophil numbers
increase neutrophil
Prior art date
Application number
AT90308198T
Other languages
English (en)
Inventor
Eric Bonnem
Lee Sullivan
Michael Grace
Loretta Bober
John Chu-Tay Tang
David Naveh
T L Nagabhushan
Jay Raman
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE119395T1 publication Critical patent/ATE119395T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
AT90308198T 1989-07-28 1990-07-26 Verwendung von interleukin-4 zur steigerung der neutrophilenzahl und zur behandlung von myeloid oder monocytoid leukeamie. ATE119395T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38693789A 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
ATE119395T1 true ATE119395T1 (de) 1995-03-15

Family

ID=23527716

Family Applications (2)

Application Number Title Priority Date Filing Date
AT90308198T ATE119395T1 (de) 1989-07-28 1990-07-26 Verwendung von interleukin-4 zur steigerung der neutrophilenzahl und zur behandlung von myeloid oder monocytoid leukeamie.
AT94105833T ATE135366T1 (de) 1989-07-28 1990-07-26 Verfahren zur reinigung von interleukin-4

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94105833T ATE135366T1 (de) 1989-07-28 1990-07-26 Verfahren zur reinigung von interleukin-4

Country Status (20)

Country Link
EP (3) EP0484380A1 (de)
JP (2) JP2580391B2 (de)
KR (1) KR100191223B1 (de)
AT (2) ATE119395T1 (de)
AU (2) AU645514B2 (de)
CA (1) CA2064753A1 (de)
DE (2) DE69017547T2 (de)
DK (2) DK0618220T3 (de)
ES (2) ES2089875T3 (de)
FI (2) FI981585L (de)
GR (1) GR3019707T3 (de)
HK (1) HK185196A (de)
HU (1) HU215257B (de)
IL (2) IL95201A0 (de)
NO (1) NO304555B1 (de)
OA (1) OA09649A (de)
RU (1) RU2082756C1 (de)
SG (1) SG44544A1 (de)
WO (1) WO1991001744A2 (de)
ZA (1) ZA905896B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
AU660942B2 (en) * 1990-09-13 1995-07-13 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
JPH07165602A (ja) * 1993-12-16 1995-06-27 Kirin Brewery Co Ltd 放射線障害防護剤
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents
US6132737A (en) * 1997-09-29 2000-10-17 Revlon Consumer Products Corporation Method for reducing sunburn cell formation with cosmetic compositions containing ascorbic acid
DK1616572T3 (da) * 1998-11-09 2010-12-06 Biogen Idec Inc Kimært anti-CD20-antistof, rituxan, til anvendelse i behandling af kronisk lymfatisk leukæmi
AU2010239463B2 (en) * 2009-04-20 2016-12-08 Galenbio, Inc. Compositions for transfection of biomolecules into cells
JP5784416B2 (ja) * 2011-08-26 2015-09-24 出光興産株式会社 菌類の回収方法
EP3995196B1 (de) * 2020-11-04 2023-08-09 Sartorius BIA Separations d.o.o. Reinigungsverfahren für lipidmembranumschlossene komplexe zusammenstellungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723000A (en) * 1983-07-05 1988-02-02 Biospectrum, Inc. Human interferon gamma and interleukin-2
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
HUT63062A (en) * 1990-03-21 1993-07-28 Schering Corp Process for producing pharmaceutical compositions increasing the immune response and comprising il-4

Also Published As

Publication number Publication date
AU661221B2 (en) 1995-07-13
HU215257B (hu) 1998-11-30
JP2580391B2 (ja) 1997-02-12
AU645514B2 (en) 1994-01-20
DE69017547D1 (de) 1995-04-13
EP0410750A3 (en) 1991-06-19
KR100191223B1 (ko) 1999-06-15
EP0410750B1 (de) 1995-03-08
DK0618220T3 (da) 1996-07-22
EP0484380A1 (de) 1992-05-13
EP0618220B1 (de) 1996-03-13
HK185196A (en) 1996-10-11
EP0618220A1 (de) 1994-10-05
DK0410750T3 (da) 1995-07-10
IL95201A0 (en) 1991-06-10
DE69025961D1 (de) 1996-04-18
AU6055890A (en) 1991-03-11
WO1991001744A3 (en) 1991-04-04
NO920351L (no) 1992-03-27
FI102039B1 (fi) 1998-10-15
FI981585A7 (fi) 1998-07-10
KR920700670A (ko) 1992-08-10
HU9200254D0 (en) 1992-04-28
EP0410750A2 (de) 1991-01-30
IL121897A0 (en) 1998-03-10
NO920351D0 (no) 1992-01-27
FI920367A0 (fi) 1992-01-28
JPH04506299A (ja) 1992-11-05
DE69025961T2 (de) 1996-10-31
OA09649A (en) 1993-05-15
ATE135366T1 (de) 1996-03-15
FI981585L (fi) 1998-07-10
GR3019707T3 (en) 1996-07-31
WO1991001744A2 (en) 1991-02-21
FI102039B (fi) 1998-10-15
RU2082756C1 (ru) 1997-06-27
ES2089875T3 (es) 1996-10-01
JPH0940575A (ja) 1997-02-10
SG44544A1 (en) 1997-12-19
HUT60146A (en) 1992-08-28
FI981585A0 (fi) 1990-07-26
NO304555B1 (no) 1999-01-11
CA2064753A1 (en) 1991-01-29
ZA905896B (en) 1991-04-24
AU5476194A (en) 1994-06-02
DE69017547T2 (de) 1995-11-02
ES2072395T3 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
DE69017547D1 (de) Verwendung von Interleukin-4 zur Steigerung der Neutrophilenzahl und zur Behandlung von Myeloid oder Monocytoid Leukeamie.
NO822871L (no) Fremgangsmaate og apparatur for stimulering av biologiske prosesser tilknyttet cellulaer aktivitet
BE863227A (fr) Procede de purification d'eaux fluorees, notamment d'eaux residuaires fluorees
AT380224B (de) Reaktor zur kontinuierlichen thermischen behandlung von verunreinigten kohlenstoffhaltigen adsorptionsmitteln
IT1079187B (it) Procedimento per sorvegliare e regolare l attivita biologica dei microorganismi in un impianto di depurazione biologica della acque di rifiuto
DE3583523D1 (de) Katalysator zur wasserstoffbehandlung von schweren kohlenwasserstoffoelen.
BR8501374A (pt) Microorganismos capazes de produzir l-carnitina e processo para preparacao de l-carnitina
JPS5421057A (en) Method of treating waste water by contact aeration process
EP0209786A3 (en) Process for purifying human tumour necrosis factor
JPS5424455A (en) Method of treating biological waste water by fluidized contact process
FI872620A7 (fi) Menetelmä jätevesien biologiseksi puhdistamiseksi
JPS5473468A (en) Biological purifying method of waste water
IT1188647B (it) Metodo per conservare pellami,pelli e pellicce grezzi
PT79827A (en) Process for re-tannig of minerally tanned hides
JPS56168750A (en) Method of treating blood purifier
IT1200128B (it) Procedimento per la tintura delle pelli e pellicce
IT1170775B (it) Procedimento per il trattamento termico di acciai legati
DE69021584D1 (de) Behandlung von abgas.
JPS5431968A (en) Method of purifying sewage by photosynthetic bacteria without dilution
ATE47889T1 (de) Verfahren zum aufbereiten von abfaellen, insbesondere von schaedliche metalle enthaltenden schlaemmen.
RO92651A2 (ro) Procedeu de prelucrare a pieilor de ovine
PL235400A1 (en) Environement pollution minimizing method of treating hides
BR8105532A (pt) Processo para o tratamento catalitico de gas bruto obtido por oxidacao parcial
RO91599A2 (ro) Procedeu de purificare a preparatelor enzimatice microbiene
JPS53137558A (en) Method of purifying and treating cattle waste water

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee